Compare · BLLN vs HUM
BLLN vs HUM
Side-by-side comparison of BillionToOne Inc. (BLLN) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.74B, about 8.1x BLLN ($5.80B).
- Over the past year, BLLN is up 14.8% and HUM is up 68.1% - HUM leads by 53.2 points.
- BLLN has been more active in the news (9 items in the past 4 weeks vs 1 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 8 for BLLN).
- Company
- BillionToOne Inc.
- Humana Inc.
- Price
- $126.01-2.45%
- $388.90-1.42%
- Market cap
- $5.80B
- $46.74B
- 1M return
- +16.83%
- +7.58%
- 1Y return
- +14.84%
- +68.08%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 9
- 1
- Recent ratings
- 8
- 25
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest BLLN
- Officer Johnson Nancy Joann sold $1,821,628 worth of shares (14,199 units at $128.29) as part of a pre-agreed trading plan, decreasing direct ownership by 67% to 6,900 units (SEC Form 4)
- BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
- SVP of Laboratory Operations Ten Bosch John Roderick sold $533,330 worth of shares (4,251 units at $125.46) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 29,301 units (SEC Form 4)
- Chief Technology Officer Tsao David exercised 20,000 shares at a strike of $2.80 and sold $2,497,698 worth of shares (20,000 units at $124.88) as part of a pre-agreed trading plan (SEC Form 4)
- BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
- Chairman and CEO Atay Oguzhan exercised 12,500 shares at a strike of $2.80 and sold $1,576,276 worth of shares (12,500 units at $126.10) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Product Officer Sakakibara Shan Riku exercised 4,000 shares at a strike of $29.82 and sold $1,000,000 worth of shares (8,000 units at $125.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 204,000 units (SEC Form 4)
- Chairman and CEO Atay Oguzhan exercised 26,250 shares at a strike of $2.80 and sold $4,729,379 worth of shares (38,750 units at $122.05) as part of a pre-agreed trading plan (SEC Form 4)
- Officer Johnson Nancy Joann sold $100,056 worth of shares (801 units at $124.91) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 21,099 units (SEC Form 4)
- SVP of Laboratory Operations Ten Bosch John Roderick sold $169,920 worth of shares (1,416 units at $120.00) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 33,552 units (SEC Form 4)
Latest HUM
- Humana upgraded by Wells Fargo with a new price target
- SEC Form 4 filed by Director Hilzinger Kurt J
- The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
- SEC Form 11-K filed by Humana Inc.
- SEC Form 11-K filed by Humana Inc.
- Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
- Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
- Humana Announces Agreement to Divest Minority Interest in Gentiva
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach